Blood serum profiling of the rat spinal nerve ligation model using ultra-performance liquid chromatography-quadrupole time-of-flight mass spectrometry

European Journal of Pharmacology

Volumn 615, Issue 1-3, 2009, Pages 61-65

  Mao, Yan Fei ^a   Liu, Xin Ru ^b   Liao, Xing Zhi ^a   Lv, Yong Hai ^b   Xu, Hua ^a   Deng, Xiao Ming ^a   Yan, Shi Kai ^b   Xiong, Yuan Chang ^a   Zhang, Wei Dong ^b  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Gabapentin; Metabolite profiling; Metabolomics; Spinal nerve ligation; UPLC Q TOF MS

Indexed keywords

GABAPENTIN; NORADRENALIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DRUG MECHANISM; EVENING DOSAGE; HYPERALGESIA; LIQUID CHROMATOGRAPHY; MALE; MECHANICAL STIMULATION; METABOLOMICS; MORNING DOSAGE; NEURALGIA; NONHUMAN; NORADRENALIN BLOOD LEVEL; PAIN THRESHOLD; PERIPHERAL NERVE INJURY; PRIORITY JOURNAL; QUADRUPOLE MASS SPECTROMETRY; RAT; SPINAL NERVE; TIME OF FLIGHT MASS SPECTROMETRY;

AMINES; ANALGESICS; ANIMALS; BIOLOGICAL MARKERS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYCLOHEXANECARBOXYLIC ACIDS; DISEASE MODELS, ANIMAL; GAMMA-AMINOBUTYRIC ACID; INJECTIONS, INTRAPERITONEAL; LIGATION; MALE; METABOLOMICS; MULTIVARIATE ANALYSIS; NOREPINEPHRINE; PERIPHERAL NERVOUS SYSTEM DISEASES; RATS; RATS, SPRAGUE-DAWLEY; SERUM; SPINAL NERVES; TANDEM MASS SPECTROMETRY;

EID: 67449126840     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2009.03.079     Document Type: Article

References (21)

1. Backonja M., Beydoun A., Edwards K.R., Schwartz S.L., Fonseca V., Hes M., LaMoreaux L., and Garofalo E. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial. JAMA 280 (1998) 1831-1836
2. Bennett G.J. Neuralgia. In: Wall P.D., and Melzack R. (Eds). Textbook of Pain. 3rd ed. (1994), Churchill Livingstone, New York 494-510
3. Bertrand S., Ng G.Y., Purisai M.G., Wolfe S.E., Severidt M.W., Nouel D., Robitaille R., Low M.J., O'Neill G.P., Metters K., Lacaille J.C., Chronwall B.M., and Morris S.J. The anticonvulsant, antihyperalgesic agent gabapentin is an agonist at brain γ-aminobutyric acid type B receptors negatively coupled to voltage-dependent calcium channels. J. Pharmacol. Exp. Ther. 298 (2001) 15-24
4. 2-adrenergic receptors in rat primary afferent neurones after peripheral nerve injury or inflammation. J. Physiol. 515 (1999) 533-542
5. Bridges D., Thompson S.W., and Rice A.S. Mechanisms of neuralgia. Br. J. Anaesth. 87 (2001) 12-26
6. Chen S.R., and Pan H.L. Hypersensitivity of spinothalamic tract neurons associated with diabetic neuropathic pain in rats. J. Neurophysiol. 87 (2002) 2726-2733
7. Cheng J.K., and Chiou L.C. Mechanisms of the antinociceptive action of gabapentin. J. Pharmacol. Sci. 100 (2006) 471-486
8. Chizh B.A., Scheede M., and Schlutz H. Antinociception and (R, S)-alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid antagonism by gabapentin in the rat spinal cord in vivo. Naunyn-Schmiedebergs Arch. Pharmacol. 362 (2000) 197-200
9. 2δ subunit of a calcium channel. J. Biol. Chem. 271 (1996) 5768-5776
10. Gu Y., and Huang L.Y. Gabapentin potentiates N-methyl-d-aspartate receptor mediated currents in rat GABAergic dorsal horn neurons. Neurosci. Lett. 324 (2002) 177-180
11. Kim S.H., and Chung J.M. An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain 50 (1992) 355-363
12. Kurvers H., Daemen M., Slaaf D., Stassen F., van den Wildenberg F., Kitslaar P., and de Mey J. Partial peripheral neuropathy and denervation induced adrenoceptor supersensitivity. Functional studies in an experimental model. Acta Orthop. Belg. 64 (1998) 64-70
13. Ng G.Y., Bertrand S., Sullivan R., Ethier N., Wang J., Yergey J., Belley M., Trimble L., Bateman K., Alder L., Smith A., McKernan R., Metters K., O'Neill G.P., Lacaille J.C., and Hébert T.E. γ-Aminobutyric acid type B receptors with specific heterodimer composition and postsynaptic actions in hippocampal neurons are targets of anticonvulsant gabapentin action. Mol. Pharmacol. 59 (2001) 144-152
14. Nicholson J.K., Connelly J., Lindon J.C., and Holmes E. Metabonomics: a platform for studying drug toxicity and gene function. Nat. Rev. Drug Discov. 1 (2002) 153-161
15. Rogawski M.A., and Löscher W. The neurobiology of antiepileptic drugs for the treatment of nonepileptic conditions. Nat. Med. 10 (2004) 685-692
16. Rowbotham M., Harden N., Stacey B., Bernstein P., and Magnus-Miller L. Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial. J. Am. Med. Assoc. 280 (1998) 1837-1842
17. Shimoyama M., Shimoyama N., and Hori Y. Gabapentin affects glutamatergic excitatory neurotransmission in the rat dorsal horn. Pain 85 (2000) 405-414
18. 2-adrenergic and muscarinic receptors and the NO release cascade mediate supraspinally produced effectiveness of gabapentin at decreasing mechanical hypersensitivity in mice after partial nerve injury. Br. J. Pharmacol. 148 (2006) 233-244
19. 2-adrenergic receptors in the effects of gabapentin on thermal and mechanical nociception after partial nerve injury in the mouse. Br. J. Pharmacol. 144 (2005) 703-714
20. Takeuchi Y., Takasu K., Honda M., Ono H., and Tanabe M. Neurochemical evidence that supraspinally administered gabapentin activates the descending noradrenergic system after peripheral nerve injury. Eur. J. Pharmacol. 556 (2007) 69-74
21. Van den Berg R.A., Hoefsloot H.C., Westerhuis J.A., Smilde A.K., and van der Werf M.J. Centering, scaling, and transformations: improving the biological information content of metabolomics data. BMC Genomics 7 (2006) 142-157